Pathfinder Therapeutics has sold its image-guided surgery system to doctors at the University of North Carolina's main campus in Chapel Hill, who will use it for liver cancer surgery. Eight-year-old Pathfinder has received backing from several big-name investors and last month received some funding from the state's INCITE co-investment fund.

"We are very excited to announce this installation at the University of North Carolina, as we continue to expand our presence in the top tier cancer and transplant centers in the United States," said Jim Cloar, CEO of Pathfinder Therapeutics. "Sales momentum, and interest from around the world continues to build for Explorer."